Reference health
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis
52/52 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 52 checked references that resolve
resolves10.1002/ana.21640
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
resolves10.1016/S1474-4422(12)70003-0
Association between pathological and MRI findings in multiple sclerosis
resolves10.1016/S1474-4422(12)70230-2
Measurement and clinical effect of grey matter pathology in multiple sclerosis
resolves10.1146/annurev-immunol-032713-120227
Immunology of Relapse and Remission in Multiple Sclerosis
resolves10.1001/archneur.57.8.1183
Changes in Activated T Cells in the Blood Correlate With Disease Activity in Multiple Sclerosis
resolves10.1212/WNL.53.4.758
Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis
resolves10.1016/j.jneuroim.2006.05.006
Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters
resolves10.1016/S0165-5728(01)00371-X
Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS
resolves10.1001/archneur.62.5.795
Kinin B1 Receptor Expression on Multiple Sclerosis Mononuclear Cells
resolves10.1093/brain/awl179
Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients
resolves10.1155/2014/875768
Determinants of Disability in Multiple Sclerosis: An Immunological and MRI Study
resolves10.1038/nm0302-295
Autoantigen microarrays for multiplex characterization of autoantibody responses
resolves10.1172/JCI23587
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays
resolves10.1016/S0896-8411(03)00064-7
Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity
resolves10.1212/01.wnl.0000223346.09426.34
Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays
resolves10.1212/WNL.0b013e318247f9f3
Antigen microarrays identify CNS-produced autoantibodies in RRMS
resolves10.1038/ni.1775
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
resolves10.1073/pnas.0806310105
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
resolves10.1212/WNL.0000000000001066
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis
resolves10.1016/j.autrev.2006.02.012
A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB study
resolves10.1002/ana.20703
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
resolves10.1111/jon.12194
Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors
resolves10.3174/ajnr.A3083
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis
resolves10.1111/j.1552-6569.2011.00589.x
The Relationships among MRI‐Defined Spinal Cord Involvement, Brain Involvement, and Disability in Multiple Sclerosis
resolves10.1016/j.neuroimage.2005.03.008
The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction
resolves10.1212/01.wnl.0000201238.93586.d9
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis
resolves10.1111/j.1552-6569.2009.00449.x
Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis
resolves10.1073/pnas.0404848101
Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes
resolves10.1016/S1474-4422(06)70349-0
The measurement and clinical relevance of brain atrophy in multiple sclerosis
resolves10.1007/s00234-011-0841-7
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
resolves10.1172/JCI22833
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
resolves10.1172/JCI29943
Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics
resolves10.1002/ana.24018
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
resolves10.1016/j.jns.2014.08.047
MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis
resolves10.1371/journal.pone.0070019
Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression
resolves10.4049/jimmunol.175.5.2777
Heat Shock Proteins as Endogenous Adjuvants in Sterile and Septic Inflammation
resolves10.1126/scitranslmed.3003831
Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation
resolves10.1016/j.jneuroim.2012.01.002
Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis
resolves10.1038/nm.3681
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
The 1 reference without a DOI — listed, not checked
no DOI — not checkedGoldschmidt Y Sharon E Quintana FJ Cohen IR Brandt A. Adaptive methods for classification of biological microarray data from multiple experiments. Report no MCS03-07. Rehovot Israel: The Arthur and Rochelle Belfer Institute of Mathematics and Computer Science; 2003.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1212/nxi.0000000000000200"><img src="https://citestamp.com/citestamped/10.1212/nxi.0000000000000200/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1212/nxi.0000000000000200)